drugset / Trial / NCT01374737

ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children

NCT01374737 ↗

Phase 4 Unknown 25 enrolled Seoul National University Hospital
Non-randomizedSingle-groupQuadruple-blindPrevention

Summary

There are several recommended doses of dexmedetomidine for prevention of emergence agitation in children. In this study, the investigators examine ED50 in prevention of emergence agitation after tonsillectomy or adenoidectomy in children.

Timeline

Start
2011-06
Primary completion
2011-12
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.1 ug/kg —

Indications

No indication recorded.